Jefferies Upgrades Chemed to Buy, Raises Price Target to $620
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsUpgradesPrice Target
Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $520 to $620.
Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $520 to $620.